RARA CRAFT DATABASE for FDA Medical Devices
510(k)K261465

FDA DEVICE FACTS

INDIRA CLOUD VIEWER

INDIGO TECHNOLOGIES

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJuly 6, 2026PRODUCT CODELLZCLINICAL AREARadiology

Indications for use

The Indira Cloud Viewer is a visualization software intended to process and display image and associated data in a clinical setting. The software displays images of different modalities and timepoints, and performs digital image processing, measurement, manipulation, quantification and communication. The Indira Cloud viewer is a web -based application and does not perform automated diagn osis and is not intended to replace clinical judgment Verification and validation:

The verification and validation activities for the Indira Cloud Viewer were conducted in accordance with a comprehensive quality and regulatory framework aligned with internationally recognized standards.

Software lifecycle processes followed IEC 62304:2006 + AMD1:2015, including software development planning, requirements definition, architectural design, implementation, and systematic verification and validation. Traceability between requirements, risk controls, and test cases was maintained throughout the lifecycle.

Risk management activities were performed in accordance with ISO 14971:2019. Hazards, including those related to software functionality, usability, and cybersecurity, were identified and evaluated. Risk control measures were implemented and verified to ens ure that residual risks are acceptable and that the benefit-risk profile supports safe and effective use.

Information security considerations were addressed in alignment with ISO/IEC 27001:2022, ensuring appropriate controls for data protection, access management, and system integrity within the cloud-based environment.

Cybersecurity principles were applied following AAMI TIR57 and AAMI TIR97, covering both premarket secure design and postmarket monitoring, vulnerability management, and incident response processes.

Usability engineering activities were conducted in accordance with IEC 62366 -1:2015 + AMD1:2020 to minimize use-related risks. The user interface and workflows were evaluated to ensure safe and effective interaction by intended users in the intended use environment.

Verification activities included unit, integration, and system-level testing, as well as performance and regression testing. Validation activities confirmed that the software meets user needs and intended use in representative clinical scenarios.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: July 28, 2026